-
1.
公开(公告)号:JP2002322150A
公开(公告)日:2002-11-08
申请号:JP2002073851
申请日:2002-03-18
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE FRANCOISE , ROUSSEAU ANNE , BOUTIN JEAN-ALBERT , DELAGRANGE PHILIPPE
IPC: C07D491/056 , A61K31/40 , A61K31/403 , A61K31/407 , A61K31/5377 , A61P3/04 , A61P3/10 , A61P5/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P35/00 , A61P43/00 , C07D209/80 , C07D209/94
Abstract: PROBLEM TO BE SOLVED: To provide a compound which exerts a useful pharmacological characteristic toward melatoninergic receptors. SOLUTION: The compound represented by formula (I), not including indeno[1,2-b]indol-10(5H)-one, is provided [wherein, R is H or an arbitrarily substituted alkenyl or an alkyl group; R1 , R2 , R3 , R4 , R5 , R6 , R7 and R8 are each H, an alkyl, an alkenyl, a hydroxy, an alkoxy, an alkenyloxy, an arylalkyl, an arylalkoxy, a carboxy, an acyloxy or an arylcarbonyloxy group, or one of R1 to R8 groups forms an alkylenedioxy group with a group adjacent to the one of R1 to R8 ]. In the compound, when R is not H, at least one of R1 to R8 groups is a hydroxy or an acyloxy group.
-
2.
公开(公告)号:JP2002265469A
公开(公告)日:2002-09-18
申请号:JP2002065233
申请日:2002-03-11
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE FRANCOISE , ROUSSEAU ANNE , BOUTIN JEAN-ALBERT , DELAGRANGE PHILIPPE
IPC: C07D487/06 , A61K31/407 , A61P3/04 , A61P3/10 , A61P9/00 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07D487/04
Abstract: PROBLEM TO BE SOLVED: To provide a medicine which contains a compound having high affinity with a melatonin receptor and is useful for treating diseases related to the melatonin operation system. SOLUTION: The compound represented by the formula (R1 , R2 , R3 , R4 , R5 , R6 , and R8 are each H or the like, R7 is H or the like, or one of R1 to R8 forms a 1 to 2C alkylenedioxy together with another adjacent one of R1 to R8 ), its optically isomer (when the optical isomer exists), and its pharmacologically acceptable acid or base adduct; a process for preparing the same; and a pharmaceutical composition containing the same.
-
公开(公告)号:HU226674B1
公开(公告)日:2009-06-29
申请号:HU0201024
申请日:2002-03-19
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , BOUTIN JEAN-ALBERT , DELAGRANGE PHILIPPE
IPC: C07D209/94 , C07D491/056 , A61K31/40 , A61K31/403 , A61K31/407 , A61K31/5377 , A61P3/04 , A61P3/10 , A61P5/00 , A61P9/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P35/00 , A61P43/00 , C07D209/80
Abstract: Compound of formula (I):wherein:R represents hydrogen or a group selected from alkenyl and optionally substituted alkyl,each of R1 to R8, which may be identical or different, represents hydrogen or a group selected from alkyl, alkenyl, hydroxy, alkoxy, alkenyloxy, arylalkyl, arylalkoxy, carboxy, acyloxy and arylcarbonyloxy,or one of R1 to R8 forms with an adjacent one R1 to R8 an alkylenedioxy group,its optical isomers when they exist, and addition salts thereof with a pharmaceutically acceptable acid or base,with the proviso that:when R does not represent hydrogen, then at least one of R1 to R8 represents hydroxy or acyloxy,and the compounds of formula (I) are other than indeno[1,2-b]indol-10(5H)-one and medicinal products containing the same which are useful for treatment of disorders of the melatoninergic system.
-
公开(公告)号:DE60205538D1
公开(公告)日:2005-09-22
申请号:DE60205538
申请日:2002-06-12
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , ATASSI GHANEM , HICKMAN JOHN , PIERRE ALAIN , LEONCE STEPHANE , GUILBAUD NICOLAS , KRAUS-BERTHIER LAURENCE
IPC: C07D209/80 , A61K31/403 , A61K31/433 , A61K31/4439 , A61P35/00 , C07D209/94 , C07D401/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D491/04 , C07D491/056 , A61K31/407
Abstract: Indenoindolone derivatives (I), their isomers and salts with acids and bases are new. Indenoindolone derivatives (I), their isomers and salts with acids and bases are new; R = H, alkyl (optionally substituted by carboxy, alkoxycarbonyl, or NR10R11), or alkenyl; R1-R8 = H, alkyl (optionally substituted by aryl, carboxy or alkoxycarbonyl), OH, acyloxy, NR12R13, carboxy, alkoxy (optionally substituted by aryl or NR14R15), alkenyloxy, or to adjacent groups R1-R8 = 1 or 2C alkylenedioxy; R9 = H, aryl, heteroaryl or alkyl (optionally containing one or more unsaturations and optionally substituted by one or more aryl, heteroaryl, 3-8C cycloalkyl, CN, or NR17R18 groups); X = O or NR16; R10, R11, R14, R15, R17, R18 = alkyl; NR10+R11, NR14+R15, NR17+R18 = nitrogen heterocycle; R12, R13 = H, alkyl, or NR14R15; R16 = H, alkyl, aryl, or aryl alkyl. Where alkyl, alkoxy, acyloxy, alkenyl and alkenyloxy groups have up to 6 C atoms, aryl is defined as phenyl, biphenyl, or naphthyl (optionally substituted by one or more halogen, alkyl, alkenyl, alkoxy, phenoxy, nitro, CN, amino, mono- and di-alkylamino or 1-2C alkylenedioxy groups) and heteroaryl groups may be mono- or bicyclic of 5-12 members with 1-3 heteroatoms (O, N, S) and optionally substituted by halogen, alkyl, OH, alkoxy, polyhaloalkyl, amino, mono- and di-alkylamino groups, and nitrogen heterocycles are monocyclic having 5-7 members including 1-3 heteroatoms, one of which is N and the others may be O, N, or S. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:ES2206438T3
公开(公告)日:2004-05-16
申请号:ES02290598
申请日:2002-03-11
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , BOUTIN JEAN-ALBERT , DELAGRANGE PHILIPPE
IPC: C07D487/06 , A61K31/407 , A61P3/04 , A61P3/10 , A61P9/00 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07D487/04
Abstract: Compound of formula (I):wherein:R1, R2, R3, R4, R5, R6 and R8, which may be identical or different, each represents hydrogen, alkyl, arylalkyl, hydroxy, alkoxy, arylalkoxy, acyloxy, arylcarbonyloxy, carboxyalkyl or carboxy,R7 represents hydrogen, hydroxy, alkoxy, arylalkoxy, acyloxy or arylcarbonyloxy group,or one of R1 to R8, together with another of R1 to R8 adjacent to it, forms an alkylenedioxy,its optical isomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
-
公开(公告)号:AR034861A1
公开(公告)日:2004-03-24
申请号:ARP020100952
申请日:2002-03-18
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , BOUTIN JEAN-ALBERT , DELAGRANGE PHILIPPE
IPC: C07D491/056 , A61K31/40 , A61K31/403 , A61K31/407 , A61K31/5377 , A61P3/04 , A61P3/10 , A61P5/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P35/00 , A61P43/00 , C07D209/80 , C07D209/94 , A61P25/00 , A61P25/08
Abstract: Un compuesto de indenoindolona de fórmula (1), en donde: R representa un átomo de hidrógeno o un grupo alquenilo C1-6 lineal o ramificado o alquilo C1-6 lineal o ramificado, opcionalmente sustituido por un grupo carboxi o por un grupo de fórmula -NRaRb en donde cada uno de Ra y Rb, que pueden ser iguales o diferentes, representan un átomo de hidrógeno o un grupo alquilo C1-6 lineal o ramificado, o forman junto con el átomo de nitrógeno que los lleva un heterociclo que contiene nitrógeno; cada uno de R1, R2, R3, R4, R5, R6, R7 y R8, que pueden ser iguales o diferentes, representan un átomo de hidrógeno o un grupo alquilo C1-6 lineal o ramificado, alquenilo C1-6 lineal o ramificado, hidroxi, alcoxi C1-6 lineal o ramificado, alqueniloxi C1-6 lineal o ramificado, arilo-alquilo C1-6 en donde la mitad alquilo es lineal o ramificada, arilo-alcoxi C1-6 en donde la mitad alcoxi es lineal o ramificada, carboxi, aciloxi C1-6 lineal o ramificado o arilcarboniloxi; o uno de los grupos R1 a R8 forma con uno adyacente de los grupos R1 a R8 un grupo alquilenodioxi C1-2, sus isómeros ópticos, cuando existen, y sales de adición de los mismos con un ácido o una base farmacéuticamente aceptable; con la condición de que: cuando R no representa un átomo de hidrógeno, entonces por lo menos uno de los grupos R1 a R8 representa un grupo hidroxi o alcoxi C1-6 lineal o ramificado; y los compuestos de fórmula (1) son distintos de indeno[1,2-b]indol-10(5H)-ona; entendiéndose que el término "arilo" significa fenilo, bifenililo, naftilo, o tetrahidronaftilo, siendo cada uno de estos grupos opcionalmente sustituido por uno o más átomos o grupos iguales o diferentes seleccionados entre átomos de halógeno y grupos alquilo C1-6 lineales o ramificados, grupos hidroxi, alcoxi C1-6 lineales o ramificados, polihaloalquilo C1-6 lineales o ramificados, grupos amino (opcionalmente sustituidos por uno o más grupos alquilo C1-6 lineales o ramificados), grupos nitro, acilo C1-6 lineales o ramificados y alquilenodioxi C1-2. También se divulga un procedimiento para la preparación del compuesto y una composición farmacéutica que lo comprende. El compuesto y la composición farmacéutica que lo comprende han probado ser útiles en el tratamiento de los trastornos del sistema melatoninérgico.
-
公开(公告)号:DK1241169T3
公开(公告)日:2003-11-24
申请号:DK02290598
申请日:2002-03-11
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , BOUTIN JEAN-ALBERT , DELAGRANGE PHILIPPE
IPC: C07D487/06 , A61K31/407 , A61P3/04 , A61P3/10 , A61P9/00 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07D487/04
Abstract: Compound of formula (I):wherein:R1, R2, R3, R4, R5, R6 and R8, which may be identical or different, each represents hydrogen, alkyl, arylalkyl, hydroxy, alkoxy, arylalkoxy, acyloxy, arylcarbonyloxy, carboxyalkyl or carboxy,R7 represents hydrogen, hydroxy, alkoxy, arylalkoxy, acyloxy or arylcarbonyloxy group,or one of R1 to R8, together with another of R1 to R8 adjacent to it, forms an alkylenedioxy,its optical isomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
-
公开(公告)号:DE60200023D1
公开(公告)日:2003-10-02
申请号:DE60200023
申请日:2002-03-11
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , BOUTIN JEAN-ALBERT , DELAGRANGE PHILIPPE
IPC: C07D487/06 , A61K31/407 , A61P3/04 , A61P3/10 , A61P9/00 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07D487/04
Abstract: Compound of formula (I):wherein:R1, R2, R3, R4, R5, R6 and R8, which may be identical or different, each represents hydrogen, alkyl, arylalkyl, hydroxy, alkoxy, arylalkoxy, acyloxy, arylcarbonyloxy, carboxyalkyl or carboxy,R7 represents hydrogen, hydroxy, alkoxy, arylalkoxy, acyloxy or arylcarbonyloxy group,or one of R1 to R8, together with another of R1 to R8 adjacent to it, forms an alkylenedioxy,its optical isomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
-
公开(公告)号:BR0202279A
公开(公告)日:2003-04-29
申请号:BR0202279
申请日:2002-06-13
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRACOISE , ROUSSEAU ANNE , ATASSI GHANAEM , HICKMAN JOHN , PIERRE ALAIN , LEONCE STEPHANE , GUILBAUD NICOLAS , KRAUS-BERTHIER LAURENCE
IPC: C07D209/80 , A61K31/403 , A61K31/433 , A61K31/4439 , A61P35/00 , C07D209/94 , C07D401/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D491/04 , C07D491/056 , A61K31/15 , A61K31/407 , C07D209/56
Abstract: Indenoindolone derivatives (I), their isomers and salts with acids and bases are new. Indenoindolone derivatives (I), their isomers and salts with acids and bases are new; R = H, alkyl (optionally substituted by carboxy, alkoxycarbonyl, or NR10R11), or alkenyl; R1-R8 = H, alkyl (optionally substituted by aryl, carboxy or alkoxycarbonyl), OH, acyloxy, NR12R13, carboxy, alkoxy (optionally substituted by aryl or NR14R15), alkenyloxy, or to adjacent groups R1-R8 = 1 or 2C alkylenedioxy; R9 = H, aryl, heteroaryl or alkyl (optionally containing one or more unsaturations and optionally substituted by one or more aryl, heteroaryl, 3-8C cycloalkyl, CN, or NR17R18 groups); X = O or NR16; R10, R11, R14, R15, R17, R18 = alkyl; NR10+R11, NR14+R15, NR17+R18 = nitrogen heterocycle; R12, R13 = H, alkyl, or NR14R15; R16 = H, alkyl, aryl, or aryl alkyl. Where alkyl, alkoxy, acyloxy, alkenyl and alkenyloxy groups have up to 6 C atoms, aryl is defined as phenyl, biphenyl, or naphthyl (optionally substituted by one or more halogen, alkyl, alkenyl, alkoxy, phenoxy, nitro, CN, amino, mono- and di-alkylamino or 1-2C alkylenedioxy groups) and heteroaryl groups may be mono- or bicyclic of 5-12 members with 1-3 heteroatoms (O, N, S) and optionally substituted by halogen, alkyl, OH, alkoxy, polyhaloalkyl, amino, mono- and di-alkylamino groups, and nitrogen heterocycles are monocyclic having 5-7 members including 1-3 heteroatoms, one of which is N and the others may be O, N, or S. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:NZ517855A
公开(公告)日:2002-10-25
申请号:NZ51785502
申请日:2002-03-18
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , BOUTIN JEAN-ALBERT , DELAGRANGE PHILIPPE
IPC: C07D491/056 , A61K31/40 , A61K31/403 , A61K31/407 , A61K31/5377 , A61P3/04 , A61P3/10 , A61P5/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P35/00 , A61P43/00 , C07D209/80 , C07D209/94 , C07D413/06
Abstract: A compound of formula (I), wherein: R is H or a linear or branched alkenyl or linear or branched alkyl group optionally substituted by a carboxy group or by a group of the formula -NRaRb. Each of R1-R8 independently represents H or a linear or branched alkyl group, a linear or branched alkenyl group, a hydroxy group, a linear or branched alkoxy group, a linear or branched alkenyloxy group, an arylalkyl group in which the alkyl moiety is linear or branched, an arylalkoxy group in which the alkoxy group is linear or branched, a carboxy group, a linear or branched acyloxy group, or an arylcarbonyloxy group. Or one of the groups R1 to R8 forms with an adjacent one of the groups R1 to R8 a (C1-C2)alkylenedioxy group. With the proviso that: i) When R does not represent a H atom, then at least one of the groups R1 to R8 represents a hydroxy group or a linear or branched acyloxy group. ii) The compounds of formula (I) are other than [1,2-b]indol-10(5H)-one. Also described are pharmaceutical compositions comprising the compound of formula (I) in combination with one or more inert, non-toxic pharmaceutically acceptable carriers. The compounds of formula (I) are useful for treating disorders of the melatoninergic system.
-
-
-
-
-
-
-
-
-